Biotechnology manufacturer
Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. 
Medicare reimbursement for transformative therapies.
H.R. 3, the Lower Drug Costs Now Act.
S. 2543, the Prescription Drug Price Reduction Act.
S. 2456, the Safe Step Act.
H.R. 1730, the Cancer Drug Parity Act.
S. 741, the Cancer Drug Parity Act. 
H.R. 985, the FAST Generics Act.
S. 340, the CREATES Act.
H.R. 965, the CREATES Act.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BAKER & HOSTETLER LLP
1050 Connecticut Ave NW Suite 1100, Washington, DC, 20036, US
CHRIS JONES ADAM HIGGINS TYLER THOMPSON